Home › PAREXEL Expands Model-Based Drug Development Offering
 

Keywords :   


PAREXEL Expands Model-Based Drug Development Offering

2015-07-10 05:41:00| drugdiscoveryonline News Articles

PAREXEL International Corporation, a leading global biopharmaceutical services provider, recently announced expanded services and capabilities in model-based drug development (MBDD) through their Quantitative Clinical Development (QCD) group.

Tags: development drug offering expands

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.11H0599bikke8.7AH
27.11 staff
27.11 TWINS 8oz
27.11
27.1120194
27.11V 7
27.1120th
27.11Under Armour Tactical T /2
More »